Please register your interest using the form. We expect to have an investor portal opening soon to provide you with real time updates and Company communication.

Corporate Profile

Releaf Dispensary Ltd (“Releaf”) is a sophisticated health and technology entrant to the UK’s growing medicinal cannabis sector. The Company transforms how patients acquire, use and experience medicinal cannabis, through an exciting, all-in-one monthly subscription that truly delivers safety, convenience, and choice for patients.

Releaf has changed the game and completely rewritten the flow, giving patients a perfectly balanced brand between clinical and lifestyle, offering patients the first all-in-one cannabis solution. Releaf has spent a great deal of time working with user experience professionals, award-winning designers, and developers to build an industry-leading website and a custom back-end platform to manage the entire customer life cycle.

We believe that patients should have access to the treatment they need, without the stigma or hefty price tag. Our service is tailored to each individual patient and our experts provide top-quality care, with ongoing support and adjustments as needed. We believe that medicinal cannabis is an essential and effective treatment for a wide range of conditions, including chronic pain, insomnia and neurological diseases. Our goal is to break down the stigma and mystery attached to medical cannabis, to provide safe and affordable healthcare to patients all over the UK.

We prescribe, dispense monthly and give the users everything they need to start their cannabis treatment plan. In addition, patients will be given a luxury welcome pack containing a premium grinder, storage container, vaporiser and the all-important Releaf medicinal cannabis card. Releaf carefully selected each item that contains our branding to ensure it is of superior quality, making every interaction with our brand have a quality feel.

Investor Information

Releaf is currently raising funds from certified High-Net-Worth Investors and Sophisticated Investors only. Should you wish to contact the Company for information about the process, please email The Company is not in a position to give financial advice and you should speak to your financial advisor before making any decision.

Receiving Agent and Releaf:

For the interest of transparency, the Company is using a Receiving Agent (Robert Lewis Accountant). Only funds transferred directly to the receiving agent's account or our own account listed on the application form, or by cheque will be considered received by Releaf. If you are in any doubt as to whether your funds have been received, please contact The Company is not responsible for funds transferred to any other party other than the ones listed below.

Escrow: Robert Lewis Redbond Ruggieri & Co Limited Direct:

Releaf Dispensary Ltd

Bank details available on request

Investor Communication and Portal:

All official investor communication from Releaf will be posted on this page and emailed from the account. We may from time to time post investor updates via third party sources such as the LSE, however all communications can be verified by what's on this page. Releaf takes no responsibility for unauthorised communications through external parties and websites and investors should place no reliance on them.

Releaf will be launching an Investor Portal with individual logins to receive up-to-date company information as we progress through our development program. Details will be announced through the investor communication email including how to register and sign up. If you are a current investor, please fill out the attached form to register for the upcoming portal. We will match the details to the information we have on file and issue you with a login password to our Investor Portal when it is ready.

Please contact for further information regarding the Company. Should you wish to discuss anything else, see relevant contact details on our contact page.

Register your interest


High Net Worth Individual: An individual with an annual income to the value of £100,000 or more and/ or net assets to the value of £250,000 or more (cannot include your home residence), throughout the financial year immediately preceding today’s date

Sophisticated Investor: You have made more than one investment in an unlisted company in the two years prior to the date below and/ or currently, or have been in the two years prior to the date below, a director of a company with an annual turnover of at least £1 million.